Leukemia, Chronic Lymphocytic, B-Cell
1 clinical trials · Condition
◉ Watch Leukemia, Chronic Lymphocytic, B-Cell
| Record | Firm | Date |
|---|---|---|
| Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT03204188) | National Heart, Lung, and Blood Institute (NHLBI) | 2017-09-22 |
Track Leukemia, Chronic Lymphocytic, B-Cell automatically
Every clearance here is in the API, with alerts when new ones post.